| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a61296d570529012d0d39d3cb90cc22e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2015-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5dc34d9bfbf87e319271a6ffb33246b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee4d6136eac487879cd84235f339651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4026779e3d14adf0c03463eff3b4db5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ad5ca28c0783d50bd22203218269a2 |
| publicationDate |
2016-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016025641-A1 |
| titleOfInvention |
Combinations of an erk inhibitor and an egfr inhibitor and related methods |
| abstract |
The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with one or both of ERK1 and ERK2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10464946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017116193-A1 |
| priorityDate |
2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |